Navigation Links
Boston Healthcare Acquires Alpha Care GmbH, Expanding Health Economics, Pricing and Reimbursement Consulting Presence in Europe
Date:5/23/2011

BOSTON and BERLIN, May 23, 2011 /PRNewswire/ -- Boston Healthcare announced today that it has acquired Alpha Care GmbH, a consulting firm based in Germany that provides health economics and policy solutions for pharmaceutical, medical device, payer and provider organizations. Through this acquisition, Boston Healthcare will expand its health economics, pricing and market access consulting practice in Europe. The establishment of a new office in Berlin, Germany, will allow Boston Healthcare to enhance the delivery of its services to global pharmaceutical, medical device and diagnostics companies.

(Logo: http://photos.prnewswire.com/prnh/20110523/NE04879LOGO)

The Berlin office will be led by Prof. Bernd Brueggenjuergen, MD, MPH, who will continue as Managing Director at Boston Healthcare GmbH, and will support global clients in market access, pricing, reimbursement and funding policies in Germany, complementing Boston Healthcare's global services. Prior to co-founding Alpha Care with Prof. Stefan Willich of the University Medicine Berlin Charite, Prof. Brueggenjuergen served as Head of Health Economics and Disease Management at GlaxoWellcome in Germany, and is currently Professor of Health Economics at the Steinbeis University in Berlin. "Securing access to innovation in health care is a key issue in all major markets and increasingly requires a global exchange and expertise," said Prof. Brueggenjuergen.

"The addition of Prof. Brueggenjuergen, and his colleagues, to the Boston Healthcare team will provide our clients with enhanced in-market support in health economics and market access in Europe," said Joseph V. Ferrara, President of Boston Healthcare. "Germany is one of the largest pharmaceutical and medical device markets in the world, as well as a leader in health care technology innovation. Our presence in Germany will enhance our ability to serve these innovative companies."

About Boston Healthcare:

Boston Healthcare helps biopharmaceutical, medical device and diagnostics companies unlock the value of innovation in the global health care marketplace. Clients rely on Boston Healthcare to create opportunities, navigate complexity, grow their businesses, and achieve their objectives through reimbursement and market access strategy, health economics and outcomes analysis, market and pricing strategies, and business development support - all delivered to help clients maximize value capture. 

For more information, please visit www.bostonhealthcare.com.   

Contact: Michal Taton
Company: Boston Healthcare Associates, Inc.
Phone: (617) 482-4004


'/>"/>
SOURCE Boston Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... 7, 2016 Boehringer Ingelheim today announced ... with unresectable malignant pleural mesothelioma (MPM) met its ... presented at the 17 th IASLC World ... , showed nintedanib plus pemetrexed/cisplatin demonstrated a ... with a significantly improved PFS (9.4 vs 5.7 ...
(Date:12/7/2016)... , December 7, 2016 Today, Stock-Callers.com ... (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ... ), and AveXis Inc. (NASDAQ: AVXS ). From ... fell roughly 37% to reach a level equal to what ... down by approximately 14% for the year, it has still ...
Breaking Medicine Technology:
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes ... and around the nation. What do they have in common? All have been affected ... compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... financial consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, ... a basketball coach who needs treatment for a brain tumor. , Jason Bauer ...
(Date:12/7/2016)... , ... December 07, 2016 , ... One of two ... of the securement tape is painful for her. "This is why the co-inventor and ... heads," she said. , They then created a prototype of the patent-pending AV-AIR, a ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... ... new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... The study was published in the prestigious Journal of Veterinary Science & Medical ...
Breaking Medicine News(10 mins):